DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Sep 9, 2025, 8:00 PM EDT
DMK Pharmaceuticals Market Cap
DMK Pharmaceuticals has a market cap or net worth of $10.00 as of September 11, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
10.00
Enterprise Value
n/a
Revenue
3.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 3, 2009, DMK Pharmaceuticals's market cap has decreased from 29.45M to 10.00, a decrease of -100.00%. That is a compound annual growth rate of -59.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 10.00 | - |
| Dec 31, 2024 | 10.00 | -100.00% |
| Dec 29, 2023 | 7.07M | -72.16% |
| Dec 30, 2022 | 25.39M | -71.81% |
| Dec 31, 2021 | 90.08M | 98.26% |
| Dec 31, 2020 | 45.43M | 5.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 375.53M |
| American Oncology Network | 353.52M |